Wei-Chieh Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wei-Chieh Cheng has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
Huang-Yi Li
Genomics Research Center, Academia Sinica, 128, Section 2, Academia Road, Taipei, 11529, Taiwan
8 shared publicationsCheng-Kun Lin
Genomics Research Center, Academia Sinica, Taipei, Taiwan
6 shared publicationsWen-Yi Yun
Genomics Research Center, Academia Sinica, 128, Section 2, Academia Road, Taipei, 11529, Taiwan
6 shared publications- Chi-Huey Wong
Genomics Research Center, Academia Sinica, Taipei 115, Taiwan
5 shared publications Ting-Jen R. Cheng
Genomics Research Center, Academia Sinica, 128, Section 2, Academia Road, Taipei, 11529, Taiwan
5 shared publicationsYi-Fan Chang
Genomics Research Center, Academia Sinica, 128, Section 2, Academia Road, Taipei, 11529, Taiwan.and Department of Chemistry, National Cheng Kung University, 1, University Road, Tainan City, 701, Taiwan
5 shared publications
Latest Publications
- 22 September 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 165, 108994
Design and synthesis of polyhydroxylated azabicyclo[3.3.1]nonane as selective lysosomal α-glucosidase stabilizers enhancing cellular uptake
- 22 September 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 165, 108994
Design and synthesis of polyhydroxylated azabicyclo[3.3.1]nonane as selective lysosomal α-glucosidase stabilizers enhancing cellular uptake
- Open Access
- 20 April 2024
- Published by Springer Nature in Communications Chemistry
- Vol. 7 (1) , 1-9
A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease
Isofagomine (IFG) and its analogues possess promising glycosidase inhibitory activities. However, a flexible synthetic strategy toward both C5a-functionalized IFGs remains to be explored. Here we show a practical synthesis of C5a-S and R aminomethyl IFG-based derivatives via the diastereoselective addition of cyanide to cyclic nitrone 1. Nitrone 1 was conveniently prepared on a gram scale and in high yield from inexpensive (−)-diethyl d-tartrate via a straightforward method, with a stereoselective Michael addition of a nitroolefin and a Nef reaction as key steps. A 268-membered library (134 × 2) of the C5a-functionalized derivatives was submitted to enzyme- or cell-based bio-evaluations, which resulted in the identification of a promising β-glucocerebrosidase (GCase) stabilizer demonstrating a 2.7-fold enhancement at 25 nM in p.Asn370Ser GCase activity and a 13-fold increase at 1 μM in recombinant human GCase activity in Gaucher cell lines.
- 20 April 2024
- Published by Springer Nature in Communications Chemistry
- Vol. 7 (1) , 1-9
Open AccessA practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease
Isofagomine (IFG) and its analogues possess promising glycosidase inhibitory activities. However, a flexible synthetic strategy toward both C5a-functionalized IFGs remains to be explored. Here we show a practical synthesis of C5a-S and R aminomethyl IFG-based derivatives via the diastereoselective addition of cyanide to cyclic nitrone 1. Nitrone 1 was conveniently prepared on a gram scale and in high yield from inexpensive (−)-diethyl d-tartrate via a straightforward method, with a stereoselective Michael addition of a nitroolefin and a Nef reaction as key steps. A 268-membered library (134 × 2) of the C5a-functionalized derivatives was submitted to enzyme- or cell-based bio-evaluations, which resulted in the identification of a promising β-glucocerebrosidase (GCase) stabilizer demonstrating a 2.7-fold enhancement at 25 nM in p.Asn370Ser GCase activity and a 13-fold increase at 1 μM in recombinant human GCase activity in Gaucher cell lines.
- Open Access
- 23 February 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (3) , 908-918
Mechanistic Insights into Dibasic Iminosugars as pH-Selective Pharmacological Chaperones to Stabilize Human α-Galactosidase
The use of pharmacological chaperones (PCs) to stabilize specific enzymes and impart a therapeutic benefit is an emerging strategy in drug discovery. However, designing molecules that can bind optimally to their targets at physiological pH remains a major challenge. Our previous study found that dibasic polyhydroxylated pyrrolidine 5 exhibited superior pH-selective inhibitory activity and chaperoning activity for human α-galactosidase A (α-Gal A) compared with its monobasic parent molecule, 4. To further investigate the role of different C-2 moieties on the pH-selectivity and protecting effects of these compounds, we designed and synthesized a library of monobasic and dibasic iminosugars, screened them for α-Gal A-stabilizing activity using thermal shift and heat-induced denaturation assays, and characterized the mechanistic basis for this stabilization using X-ray crystallography and binding assays. We noted that the dibasic iminosugars 5 and 20 protect α-Gal A from denaturation and inactivation at lower concentrations than monobasic or other N-substituted derivatives; a finding attributed to the nitrogen on the C-2 methylene of 5 and 20, which forms the bifurcated salt bridges (BSBs) with two carboxyl residues, E203 and D231. Additionally, the formation of BSBs at pH 7.0 and the electrostatic repulsion between the vicinal ammonium cations of dibasic iminosugars at pH 4.5 are responsible for their pH-selective binding to α-Gal A. Moreover, compounds 5 and 20 demonstrated promising results in improving enzyme replacement therapy and exhibited significant chaperoning effects in Fabry cells. These findings suggest amino-iminosugars 5 and 20 as useful models to demonstrate how an additional exocyclic amino group can improve their pH-selectivity and protecting effects, providing new insights for the design of pH-selective PCs.
- 23 February 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (3) , 908-918
Open AccessMechanistic Insights into Dibasic Iminosugars as pH-Selective Pharmacological Chaperones to Stabilize Human α-Galactosidase
The use of pharmacological chaperones (PCs) to stabilize specific enzymes and impart a therapeutic benefit is an emerging strategy in drug discovery. However, designing molecules that can bind optimally to their targets at physiological pH remains a major challenge. Our previous study found that dibasic polyhydroxylated pyrrolidine 5 exhibited superior pH-selective inhibitory activity and chaperoning activity for human α-galactosidase A (α-Gal A) compared with its monobasic parent molecule, 4. To further investigate the role of different C-2 moieties on the pH-selectivity and protecting effects of these compounds, we designed and synthesized a library of monobasic and dibasic iminosugars, screened them for α-Gal A-stabilizing activity using thermal shift and heat-induced denaturation assays, and characterized the mechanistic basis for this stabilization using X-ray crystallography and binding assays. We noted that the dibasic iminosugars 5 and 20 protect α-Gal A from denaturation and inactivation at lower concentrations than monobasic or other N-substituted derivatives; a finding attributed to the nitrogen on the C-2 methylene of 5 and 20, which forms the bifurcated salt bridges (BSBs) with two carboxyl residues, E203 and D231. Additionally, the formation of BSBs at pH 7.0 and the electrostatic repulsion between the vicinal ammonium cations of dibasic iminosugars at pH 4.5 are responsible for their pH-selective binding to α-Gal A. Moreover, compounds 5 and 20 demonstrated promising results in improving enzyme replacement therapy and exhibited significant chaperoning effects in Fabry cells. These findings suggest amino-iminosugars 5 and 20 as useful models to demonstrate how an additional exocyclic amino group can improve their pH-selectivity and protecting effects, providing new insights for the design of pH-selective PCs.
- 24 June 2022
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 5 (9) , 12374-12379
Versatile Azido-Functionalized Carbon Dots for Cancer Cell Imaging
- 24 June 2022
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 5 (9) , 12374-12379
Versatile Azido-Functionalized Carbon Dots for Cancer Cell Imaging
- 23 May 2022
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 17 (14) , e202200172
Synthesis of Nitrone‐derived Pyrrolidine Scaffolds and Their Combinatorial Libraries to Develop Selective α‐l‐Rhamnosidase Inhibitors
A general and flexible approach toward the development of α‐l‐rhamnosidase (α‐l‐Rha‐ase) inhibitors is described. Five enantiopure poly‐substituted pyrrolidine‐based scaffolds bearing the C1‐aminomethyl moiety were designed and synthesized from five‐membered cyclic nitrones. Each structurally diversified amide library of these scaffolds was rapidly generated via combinatorial parallel synthesis and applied for in‐situ inhibition study against α‐l‐Rha‐ase, allowing us to efficiently identify new inhibition hits. Surprisingly, all promising inhibitors are derived from the same scaffold 3. Among them, the most potent and selective inhibitor is pyrrolidine 19 with Ki=0.24 μM, approximately 24‐fold more potent than the reference compound DAA (Ki=5.7 μM). It is the first study to comprehensively prepare pyrrolidine‐based scaffolds and libraries for inhibition study against α‐l‐Rha‐ase.
- 23 May 2022
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 17 (14) , e202200172
Synthesis of Nitrone‐derived Pyrrolidine Scaffolds and Their Combinatorial Libraries to Develop Selective α‐l‐Rhamnosidase Inhibitors
A general and flexible approach toward the development of α‐l‐rhamnosidase (α‐l‐Rha‐ase) inhibitors is described. Five enantiopure poly‐substituted pyrrolidine‐based scaffolds bearing the C1‐aminomethyl moiety were designed and synthesized from five‐membered cyclic nitrones. Each structurally diversified amide library of these scaffolds was rapidly generated via combinatorial parallel synthesis and applied for in‐situ inhibition study against α‐l‐Rha‐ase, allowing us to efficiently identify new inhibition hits. Surprisingly, all promising inhibitors are derived from the same scaffold 3. Among them, the most potent and selective inhibitor is pyrrolidine 19 with Ki=0.24 μM, approximately 24‐fold more potent than the reference compound DAA (Ki=5.7 μM). It is the first study to comprehensively prepare pyrrolidine‐based scaffolds and libraries for inhibition study against α‐l‐Rha‐ase.
- Open Access
- 19 April 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (21) , 6233-6243
Harnessing natural-product-inspired combinatorial chemistry and computation-guided synthesis to developN-glycan modulators as anticancer agents
An integrated strategy of Natural-Product-Inspired Combinatorial Chemistry (NPICC) and Computation-Guided Synthesis is used to develop an α-hGMII inhibitor with 106-fold selectivity over α-hLM, withinhibitory effect on hepatocellular carcinoma.
- 19 April 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (21) , 6233-6243
Open AccessHarnessing natural-product-inspired combinatorial chemistry and computation-guided synthesis to developN-glycan modulators as anticancer agents
An integrated strategy of Natural-Product-Inspired Combinatorial Chemistry (NPICC) and Computation-Guided Synthesis is used to develop an α-hGMII inhibitor with 106-fold selectivity over α-hLM, withinhibitory effect on hepatocellular carcinoma.
- 23 December 2021
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 17 (4) , e202101169
Synthesis and Evaluation of Diverse N‐Substituted Disaccharide Dipeptides for Human NOD2 Stimulation Activity
A new strategy for the preparation of distinct N‐substituted muropeptides is described. Different orthogonally N‐protected disaccharide thioglycosides were designed and synthesized. Among them, compound 4, qualified as a key intermediate, was utilized for further chemical transformations to develop a series of diverse N‐substituted‐glucosaminyl N‐substituted‐muramyl dipeptides (GMDPs). These unique muropeptides were applied for the study of human NOD2 stimulation. Intriguingly, structural modification of the MurNAc residue to N‐non‐substituted muramic acid (MurNH2) in GMDP dramatically impaired NOD2 stimulatory activity, but GMDPs possessing the glucosamine residue with a free amino group retained NOD2 stimulation activity. This work is the first study to illustrate the impact of both N‐substituents of GMDPs on immunostimulatory activities of human NOD2.
- 23 December 2021
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 17 (4) , e202101169
Synthesis and Evaluation of Diverse N‐Substituted Disaccharide Dipeptides for Human NOD2 Stimulation Activity
A new strategy for the preparation of distinct N‐substituted muropeptides is described. Different orthogonally N‐protected disaccharide thioglycosides were designed and synthesized. Among them, compound 4, qualified as a key intermediate, was utilized for further chemical transformations to develop a series of diverse N‐substituted‐glucosaminyl N‐substituted‐muramyl dipeptides (GMDPs). These unique muropeptides were applied for the study of human NOD2 stimulation. Intriguingly, structural modification of the MurNAc residue to N‐non‐substituted muramic acid (MurNH2) in GMDP dramatically impaired NOD2 stimulatory activity, but GMDPs possessing the glucosamine residue with a free amino group retained NOD2 stimulation activity. This work is the first study to illustrate the impact of both N‐substituents of GMDPs on immunostimulatory activities of human NOD2.
- 4 October 2021
- Published by Wiley in ChemBioChem
- Vol. 22 (24) , 3462-3468
Harnessing Fluorescent Moenomycin A Antibiotics for Bacterial Cell Wall Imaging Studies
The imaging of peptidoglycan (PGN) dynamics in living bacteria facilitates the understanding of PGN biosynthesis and wall‐targeting antibiotics. The main tools for imaging bacterial PGN are fluorescent probes, such as the well‐known PGN metabolic labeling probes. However, fluorescent small‐molecule probes for labeling key PGN‐synthesizing enzymes, especially for transglycosylases (TGases), remain to be explored. In this work, the first imaging probe for labeling TGase in bacterial cell wall studies is reported. We synthesized various fluorescent MoeA‐based molecules by derivatizing the natural antibiotic moenomycin A (MoeA), and used them to label TGases in living bacteria, monitor bacterial growth and division cycles by time‐lapse imaging, and study cell wall growth in the mecA‐carrying methicillin‐resistant Staphylococcus aureus (MRSA) strains when the β‐lactam‐based probes were unsuitable.
- 4 October 2021
- Published by Wiley in ChemBioChem
- Vol. 22 (24) , 3462-3468
Harnessing Fluorescent Moenomycin A Antibiotics for Bacterial Cell Wall Imaging Studies
The imaging of peptidoglycan (PGN) dynamics in living bacteria facilitates the understanding of PGN biosynthesis and wall‐targeting antibiotics. The main tools for imaging bacterial PGN are fluorescent probes, such as the well‐known PGN metabolic labeling probes. However, fluorescent small‐molecule probes for labeling key PGN‐synthesizing enzymes, especially for transglycosylases (TGases), remain to be explored. In this work, the first imaging probe for labeling TGase in bacterial cell wall studies is reported. We synthesized various fluorescent MoeA‐based molecules by derivatizing the natural antibiotic moenomycin A (MoeA), and used them to label TGases in living bacteria, monitor bacterial growth and division cycles by time‐lapse imaging, and study cell wall growth in the mecA‐carrying methicillin‐resistant Staphylococcus aureus (MRSA) strains when the β‐lactam‐based probes were unsuitable.